Disposable Blood Bags Market: Challenges, Restraints & Risk Factors
Wiki Article
The global Disposable Blood Bags Market is poised for robust growth in the coming years. According to the report, the market is expected to reach a value of approximately US$ 406.2 million in 2025, and is projected to grow at a compound annual growth rate (CAGR) of ~9.5% between 2025 and 2032, to reach about US$ 765.6 million by 2032.
Blood bags form a critical component of the blood-transfusion ecosystem—used at collection, storage, processing, transport and transfusion stages. As demand for blood transfusions, blood-derived products, and improved standards of blood safety continue to rise, the market for disposable blood bags is gaining momentum.
Market Drivers
Several key factors are driving this growth:
- The global volume of blood donations is significant. The World Health Organization reports over 118.5 million blood donations collected each year worldwide.
- More than 310 million surgeries are performed globally each year, many of which require transfusions—thereby boosting demand for proper collection, storage and transport systems including disposable blood bags.
- Rising incidence of chronic diseases, trauma, accident-related injuries and rare blood disorders means greater demand for blood-derived components (RBCs, platelets, plasma, granulocytes) which rely on high-quality collection and transfer bags.
- Sustainability concerns: A shift is occurring toward phthalate-free, biodegradable and more biocompatible materials for blood bags. The report suggests that eco-friendly blood bags will be increasingly adopted (targeting ~15% adoption in 2025).
Market Segmentation
The report segments the market by product type, channel, end-user, and region:
By Product Type:
- Collection Bags (single, double, triple, quadruple)
- Transfer Bags
The collection bags segment dominated, holding around ~72.3% share in 2024, due to their critical role in initial blood collection operations.
PVC-based materials remain common, often with phthalate plasticizers to enhance flexibility; newer materials are emerging with focus on durability, biocompatibility and improved storage capabilities.
By Channel:
- Tender Sales (government contracts, blood-bank procurement)
- Private Sales
Tender sales dominated (~60.7% share in 2024), driven by large scale procurement by national blood banks and government hospitals.
By End-User:
- Blood Banks
- Hospitals
- Non-Governmental Organizations (NGOs)
Blood banks were the largest end-user segment (~62% share in 2024), owing to their central role in collection, processing and storage of donated blood. Hospitals follow, with NGOs playing niche roles in mobile camps, drives and smaller scale operations.
Download Sample PDF Of This Report: https://www.persistencemarketresearch.com/samples/11650
Regional Outlook
The growth is being driven globally, but there are regional differences:
North America:
The U.S. leads in North America, accounting for about 91.9% of the region’s market share in 2024. The expansion is supported by advanced healthcare infrastructure, high blood‐donation volumes (~6.8 million donors annually in the U.S.), and well-established blood bank networks.
Europe:
The UK is a key market within Europe, where the disposable blood bags market in the UK held ~35.0% of Europe’s share in 2024. Genetic blood disorders such as sickle cell disease and thalassemia contribute to demand.
Asia Pacific:
Emerging markets such as China and India are gaining importance. In China, ~26.7% of Asia’s disposable blood bags demand in 2024 was recorded. Growth is supported by expanding hospital networks, rural healthcare penetration and increased awareness.
However, challenges remain—particularly in regions (like parts of Africa) where infrastructure for blood collection, storage and donation remains underdeveloped, thereby constraining market growth.
Competitive Landscape & Key Trends
Major global players include Terumo Corporation, Fresenius Kabi, Macopharma, Haemonetics Corporation and Grifols S.A..
Some recent developments:
- In 2024, Macopharma launched blood bags with improved sterility indicators and enhanced storage properties.
- In September 2023, Fresenius Kabi expanded its production capacity in Asia Pacific to meet rising demand in China and India.
- Product innovation is a key trend: phthalate-free plastics, eco-friendly materials, multi-bag systems for component separation, and IoT-enabled smart blood bags equipped with sensors monitoring temperature, pH and hemolysis are emerging.
One of the most interesting opportunities is the move towards smart blood bags with embedded IoT sensors, enabling real‐time monitoring of blood condition during storage and transport. This not only improves safety and traceability but also addresses logistical challenges in the blood supply chain.
Challenges & Restraints
Despite the positive outlook, the market faces some restraints:
- Infrastructure gaps in developing regions: In many African countries, collection and storage infrastructure is limited which hampers the adoption of advanced blood bag systems and causes higher wastage of donated blood.
- Low awareness and cultural misconceptions around voluntary blood donation reduce the supply of blood donations, limiting growth for blood bags in certain geographies.
- Cost pressures: In price‐sensitive markets, adoption of high‐end, biodegradable or smart blood bags may be slow compared to traditional PVC bags.
- Regulatory and safety standards: Blood bag materials must comply with strict biocompatibility, sterility and traceability regulations, which can slow product introduction and raise R&D costs.